anmelden
Swiss All Share Index
19.830,07
PKT
+65,52
PKT
+0,33
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.04.05 | Roche Outperform | Goldman Sachs | |
| 20.04.05 | Roche Overweight | JP Morgan | |
| 25.04.05 | Helvetia Baloise Neutral | Sal. Oppenheim | |
| 19.04.05 | BB Biotech Kaufen | Hamburger Sparkasse | |
| 19.04.05 | Novartis Buy | Merrill Lynch | |
| 19.04.05 | ABB (Asea Brown Boveri) Overweight | JP Morgan | |
| 19.04.05 | Roche Halten | Helaba Trust | |
| 21.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 19.04.05 | Roche Buy | Sarasin Research | |
| 19.04.05 | Roche Akkumulieren | Independent Research | |
| 18.04.05 | UBS Market Perform | Vontobel | |
| 19.04.05 | Clariant Neutral | HypoVereinsbank | |
| 18.04.05 | Helvetia Baloise Sector Outperform | Vontobel | |
| 19.04.05 | Novartis Neutral | JP Morgan | |
| 19.04.05 | Roche Overweight | JP Morgan | |
| 18.04.05 | UBS Market Outperform | Vontobel | |
| 18.04.05 | Helvetia Baloise Accumulate | Helvea | |
| 18.04.05 | Novartis Outperform | Goldman Sachs | |
| 19.04.05 | Roche Equal weight | Lehman Brothers | |
| 18.04.05 | Swiss Prime Site Neutral | Sarasin Research | |
| 18.04.05 | Sulzer Buy | Sarasin Research | |
| 15.04.05 | Roche In-Line | Goldman Sachs | |
| 18.04.05 | ARYZTA Neutral | Sarasin Research | |
| 18.04.05 | Nestlé Neutral | Sarasin Research | |
| 19.04.05 | Helvetia Baloise Buy | Sarasin Research | |
| 18.04.05 | Novartis Neutral | HypoVereinsbank | |
| 18.04.05 | Sulzer Neutral | Helvea | |
| 18.04.05 | Roche Buy | Helvea | |
| 15.04.05 | Novartis Kaufen | Helaba Trust | |
| 15.04.05 | Roche In-Line | Goldman Sachs | |
| 18.04.05 | Novartis Neutral | Sarasin Research | |
| 18.04.05 | Roche Outperform | HypoVereinsbank | |
| 18.04.05 | Roche Buy | Sarasin Research | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | ABB (Asea Brown Boveri) Overweight | Lehman Brothers | |
| 14.04.05 | Galenica Market Perform | Vontobel | |
| 14.04.05 | Roche Halten | Helaba Trust | |
| 15.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 15.04.05 | Roche Buy | SES Research |